Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiotech Gwth Regulatory News (BIOG)

Share Price Information for Biotech Gwth (BIOG)

Share Price is delayed by 15 minutes
Get Live Data
1,448.00    44.00 (3.13%)
Bid:
1,436.00
Ask:
1,454.00
Spread: 18.00 (1.253%)
Market Cap: £278.85m
BIOG Live PriceLast checked at - London Stock Exchange

Intraday Biotech Gwth Share Chart

Total Voting Rights

2 Jan 2024 09:32

The Biotech Growth Trust Plc - Total Voting Rights

The Biotech Growth Trust Plc - Total Voting Rights

PR Newswire

LONDON, United Kingdom, January 02

The Biotech Growth Trust PLC

2 January 2024

The Biotech Growth Trust PLC

Voting Rights and Capital

In accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, The Biotech Growth Trust PLC (the "Company") announces the following:

As at 31 December 2023, the Company capital consists of ordinary shares of 25p with each ordinary share holding one voting right. The total number of ordinary shares in issue is 34,555,600. The Company has no ordinary shares in Treasury.

Therefore, the total number of voting rights in the Company is 34,555,600.

The above figure (34,555,600) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in the Company or a change to their interest in the Company, under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

- END -

Frostrow Capital LLP

Company Secretary

Tel: 0203 709 8734



Date   Source Headline
28th Nov 20251:11 pmPRNNet Asset Value(s)
27th Nov 20251:34 pmPRNNet Asset Value(s)
26th Nov 20253:23 pmPRNNet Asset Value(s)
25th Nov 20251:03 pmPRNNet Asset Value(s)
24th Nov 20251:16 pmPRNNet Asset Value(s)
21st Nov 20255:07 pmPRNTransaction in Own Shares
21st Nov 202512:27 pmPRNNet Asset Value(s)
20th Nov 20251:07 pmPRNNet Asset Value(s)
20th Nov 20257:00 amPRNHalf-year Financial Report
19th Nov 20251:55 pmPRNNet Asset Value(s)
18th Nov 20251:08 pmPRNNet Asset Value(s)
17th Nov 20251:51 pmPRNNet Asset Value(s)
14th Nov 20255:17 pmPRNTransaction in Own Shares
14th Nov 202512:00 pmPRNNet Asset Value(s)
13th Nov 20252:18 pmPRNNet Asset Value(s)
12th Nov 20254:37 pmPRNResult of General Meeting
12th Nov 20251:10 pmPRNNet Asset Value(s)
12th Nov 202511:13 amPRNMonthly Fact Sheet as at 31 October 2025
11th Nov 20251:22 pmPRNNet Asset Value(s)
10th Nov 20251:09 pmPRNNet Asset Value(s)
7th Nov 20255:35 pmPRNTransaction in Own Shares
7th Nov 20251:23 pmPRNNet Asset Value(s)
6th Nov 202512:44 pmPRNNet Asset Value(s)
5th Nov 20252:07 pmPRNNet Asset Value(s)
4th Nov 20252:13 pmPRNNet Asset Value(s)
3rd Nov 20251:56 pmPRNNet Asset Value(s)
3rd Nov 20259:47 amPRNTotal Voting Rights
31st Oct 20255:21 pmPRNTransaction in Own Shares
31st Oct 202512:14 pmPRNNet Asset Value(s)
30th Oct 20252:44 pmPRNNet Asset Value(s)
29th Oct 20252:11 pmPRNNet Asset Value(s)
28th Oct 20251:30 pmPRNNet Asset Value(s)
27th Oct 20251:49 pmPRNNet Asset Value(s)
24th Oct 20255:42 pmPRNTransaction in Own Shares
24th Oct 20252:15 pmPRNNet Asset Value(s)
23rd Oct 20253:14 pmPRNNet Asset Value(s)
22nd Oct 20252:29 pmPRNNet Asset Value(s)
21st Oct 20251:30 pmPRNNet Asset Value(s)
21st Oct 20257:00 amPRNCompliance with Market Abuse Regulation
20th Oct 20251:36 pmPRNNet Asset Value(s)
17th Oct 20255:28 pmPRNTransaction in Own Shares
17th Oct 20253:11 pmPRNNet Asset Value(s)
16th Oct 202512:28 pmPRNNet Asset Value(s)
15th Oct 20253:17 pmPRNDirector/PDMR Shareholding
15th Oct 202512:54 pmPRNNet Asset Value(s)
15th Oct 202511:12 amPRNInvestor Presentation via Investor Meet Company
15th Oct 20258:00 amPRNPublication of a circular and notice of general meeting
14th Oct 20253:17 pmPRNMonthly Fact Sheet as at 30 September 2025
14th Oct 202512:41 pmPRNNet Asset Value(s)
13th Oct 20252:18 pmPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.